Loading...
Upcoming Investor Conferences: Oculis Holding AG will participate in several investor conferences throughout September, including the Wells Fargo Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference.
Key Management Participation: CEO Riad Sherif, M.D., and CFO Sylvia Cheung will represent the company at these events, with scheduled presentations and fireside chats.
Company Updates and Webcasts: Oculis will provide updates on its clinical pipeline during the conferences, and webcast links for these presentations will be available on their website.
Focus on Innovative Treatments: Oculis is dedicated to developing solutions for ophthalmic and neuro-ophthalmic diseases, with a late-stage clinical pipeline that includes three core product candidates targeting significant unmet medical needs.
